Wenxiu Ge Selected Research

hydroxysafflor yellow A

1/2021	Corrigendum: Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy.
1/2020	Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenxiu Ge Research Topics

Disease

4	Reperfusion Injury 10/2023 - 01/2020
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 01/2020
1	Dysbiosis 01/2024
1	Colitis 01/2024
1	Ulcerative Colitis 01/2024
1	Brain Ischemia (Cerebral Ischemia) 10/2023
1	Neuroinflammatory Diseases 10/2023
1	Inflammation (Inflammations) 01/2021

Drug/Important Bio-Agent (IBA)

2	hydroxysafflor yellow AIBA 01/2021 - 01/2020
2	InflammasomesIBA 01/2021 - 01/2020
1	propionic acid (potassium propionate)IBA 01/2024
1	Dextrans (Dextran)FDA Link 01/2024
1	Dietary Fiber FDA Link 01/2024
1	Volatile Fatty AcidsIBA 01/2024
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2024
1	Butyric Acid (Butanoic Acid)IBA 01/2024
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2024
1	scutellarinIBA 10/2023
1	dibenzazepineIBA 01/2021

Therapy/Procedure

1	Therapeutics 01/2021